Cellular and Molecular Life Sciences, volume 78, issue 23, pages 7777-7794

Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2

Siniavin Andrei 1, 2
Grinkina Svetlana D 2
Mozhaeva Vera A 1, 4
Starkov Vladislav G. 1
Osipov Alexey V. 1
Lummis Sarah C.R. 5
Publication typeJournal Article
Publication date2021-10-29
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor8
ISSN1420682X, 14209071
Molecular Biology
Pharmacology
Cell Biology
Molecular Medicine
Cellular and Molecular Neuroscience
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 requires new treatments both to alleviate the symptoms and to prevent the spread of this disease. Previous studies demonstrated good antiviral and virucidal activity of phospholipase A2s (PLA2s) from snake venoms against viruses from different families but there was no data for coronaviruses. Here we show that PLA2s from snake venoms protect Vero E6 cells against SARS-CoV-2 cytopathic effects. PLA2s showed low cytotoxicity to Vero E6 cells with some activity at micromolar concentrations, but strong antiviral activity at nanomolar concentrations. Dimeric PLA2 from the viper Vipera nikolskii and its subunits manifested especially potent virucidal effects, which were related to their phospholipolytic activity, and inhibited cell–cell fusion mediated by the SARS-CoV-2 spike glycoprotein. Moreover, PLA2s interfered with binding both of an antibody against ACE2 and of the receptor-binding domain of the glycoprotein S to 293T/ACE2 cells. This is the first demonstration of a detrimental effect of PLA2s on β-coronaviruses. Thus, snake PLA2s are promising for the development of antiviral drugs that target the viral envelope, and could also prove to be useful tools to study the interaction of viruses with host cells. Supplementary Information The online version contains supplementary material available at 10.1007/s00018-021-03985-6.

Citations by journals

1
2
3
4
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 4, 14.81%
International Journal of Molecular Sciences
4 publications, 14.81%
Toxins
Toxins, 2, 7.41%
Toxins
2 publications, 7.41%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 2, 7.41%
International Journal of Biological Macromolecules
2 publications, 7.41%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 3.7%
Frontiers in Microbiology
1 publication, 3.7%
Nature Reviews Chemistry
Nature Reviews Chemistry, 1, 3.7%
Nature Reviews Chemistry
1 publication, 3.7%
Archives of Microbiology
Archives of Microbiology, 1, 3.7%
Archives of Microbiology
1 publication, 3.7%
Trends in Endocrinology and Metabolism
Trends in Endocrinology and Metabolism, 1, 3.7%
Trends in Endocrinology and Metabolism
1 publication, 3.7%
Toxicon: X
Toxicon: X, 1, 3.7%
Toxicon: X
1 publication, 3.7%
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B, 1, 3.7%
Acta Pharmaceutica Sinica B
1 publication, 3.7%
Toxicology in Vitro
Toxicology in Vitro, 1, 3.7%
Toxicology in Vitro
1 publication, 3.7%
Frontiers in Pharmacology
Frontiers in Pharmacology, 1, 3.7%
Frontiers in Pharmacology
1 publication, 3.7%
Evidence-based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine, 1, 3.7%
Evidence-based Complementary and Alternative Medicine
1 publication, 3.7%
Bulletin of Russian State Medical University
Bulletin of Russian State Medical University, 1, 3.7%
Bulletin of Russian State Medical University
1 publication, 3.7%
Russian Journal of Bioorganic Chemistry
Russian Journal of Bioorganic Chemistry, 1, 3.7%
Russian Journal of Bioorganic Chemistry
1 publication, 3.7%
Biotechnology Reports
Biotechnology Reports, 1, 3.7%
Biotechnology Reports
1 publication, 3.7%
Vaccines
Vaccines, 1, 3.7%
Vaccines
1 publication, 3.7%
Pharmaceuticals
Pharmaceuticals, 1, 3.7%
Pharmaceuticals
1 publication, 3.7%
Scientific Reports
Scientific Reports, 1, 3.7%
Scientific Reports
1 publication, 3.7%
Molecules
Molecules, 1, 3.7%
Molecules
1 publication, 3.7%
Sakarya University Journal of Science, 1, 3.7%
Sakarya University Journal of Science
1 publication, 3.7%
1
2
3
4

Citations by publishers

1
2
3
4
5
6
7
8
9
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 33.33%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 33.33%
Elsevier
Elsevier, 7, 25.93%
Elsevier
7 publications, 25.93%
Springer Nature
Springer Nature, 3, 11.11%
Springer Nature
3 publications, 11.11%
Frontiers Media S.A.
Frontiers Media S.A., 2, 7.41%
Frontiers Media S.A.
2 publications, 7.41%
Hindawi Limited
Hindawi Limited, 1, 3.7%
Hindawi Limited
1 publication, 3.7%
Pirogov Russian National Research Medical University
Pirogov Russian National Research Medical University, 1, 3.7%
Pirogov Russian National Research Medical University
1 publication, 3.7%
Pleiades Publishing
Pleiades Publishing, 1, 3.7%
Pleiades Publishing
1 publication, 3.7%
Sakarya University Journal of Science, 1, 3.7%
Sakarya University Journal of Science
1 publication, 3.7%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Siniavin A. et al. Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 // Cellular and Molecular Life Sciences. 2021. Vol. 78. No. 23. pp. 7777-7794.
GOST all authors (up to 50) Copy
Siniavin A., Streltsova M. A., Nikiforova M., Kudryavtsev D. S., Grinkina S. D., Гущин В. А., Mozhaeva V. A., Starkov V. G., Osipov A. V., Lummis S. C., Tsetlin V. I., Utkin Y. N. Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2 // Cellular and Molecular Life Sciences. 2021. Vol. 78. No. 23. pp. 7777-7794.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s00018-021-03985-6
UR - https://doi.org/10.1007%2Fs00018-021-03985-6
TI - Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2
T2 - Cellular and Molecular Life Sciences
AU - Siniavin, Andrei
AU - Streltsova, Maria A
AU - Kudryavtsev, Denis S.
AU - Grinkina, Svetlana D
AU - Гущин, В. А.
AU - Mozhaeva, Vera A
AU - Starkov, Vladislav G.
AU - Lummis, Sarah C.R.
AU - Tsetlin, V. I.
AU - Utkin, Yu. N.
AU - Osipov, Alexey V.
AU - Nikiforova, Maria
PY - 2021
DA - 2021/10/29 00:00:00
PB - Springer Nature
SP - 7777-7794
IS - 23
VL - 78
PMID - 34714362
SN - 1420-682X
SN - 1420-9071
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Siniavin,
author = {Andrei Siniavin and Maria A Streltsova and Denis S. Kudryavtsev and Svetlana D Grinkina and В. А. Гущин and Vera A Mozhaeva and Vladislav G. Starkov and Sarah C.R. Lummis and V. I. Tsetlin and Yu. N. Utkin and Alexey V. Osipov and Maria Nikiforova},
title = {Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2},
journal = {Cellular and Molecular Life Sciences},
year = {2021},
volume = {78},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1007%2Fs00018-021-03985-6},
number = {23},
pages = {7777--7794},
doi = {10.1007/s00018-021-03985-6}
}
MLA
Cite this
MLA Copy
Siniavin, Andrei, et al. “Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2.” Cellular and Molecular Life Sciences, vol. 78, no. 23, Oct. 2021, pp. 7777-7794. https://doi.org/10.1007%2Fs00018-021-03985-6.
Found error?